Related Experiment Video
Updated: Feb 24, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
Alba Torrents de la Peña1, Jean-Philippe Julien2, Steven W de Taeye1
1Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam 1105 AZ, the Netherlands.
Engineered HIV-1 envelope glycoprotein (Env) trimers with added disulfide bonds show improved stability and antigenicity. These next-generation trimers elicit stronger antibody responses, advancing vaccine development for broadly neutralizing antibodies (bNAbs).
Area of Science:
- Structural biology
- Immunology
- Virology
Background:
- Recombinant HIV-1 envelope glycoprotein (Env) trimers are crucial for vaccine development but suffer from instability and flexibility.
- The BG505 SOSIP.664 trimer is an engineered model mimicking native Env structure and antigenicity.
Purpose of the Study:
- To enhance the stability and antigenicity of SOSIP trimers by introducing new disulfide bonds.
- To assess the immunogenicity of these stabilized trimers in inducing neutralizing antibody (NAb) responses.
Main Methods:
- Introduction of novel disulfide bonds between gp120 and gp41 subunits in BG505 and other HIV-1 genotype SOSIP trimers.
- Evaluation of trimer stability, conformational flexibility, and antigenicity.
- Assessment of autologous and heterologous neutralizing antibody (NAb) responses in rabbits.
Main Results:
- New disulfide bonds significantly improved trimer stability and antigenicity, reducing conformational flexibility.
- The next-generation SOSIP.v5 trimers induced potent autologous tier-2 NAb responses.
- BG505 SOSIP.v6 trimers elicited weak heterologous NAb responses against specific tier-2 viruses.
Conclusions:
- Stabilization of SOSIP trimers via disulfide bonds is a viable strategy to improve immunogenicity.
- These methods can be applied across multiple HIV-1 genotypes for developing multivalent vaccines.
- The stabilized trimers represent a promising platform for inducing broadly neutralizing antibodies (bNAbs).
More Related Videos
07:29Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging
Published on: December 1, 2011
10:50Assessment of Immunologically Relevant Dynamic Tertiary Structural Features of the HIV-1 V3 Loop Crown R2 Sequence by ab initio Folding
Published on: September 15, 2010